Sodium Chloride Injection Recalled for Manufacturing Control Deviations
Nephron Pharmaceuticals is recalling 378 bags of 0.9% Sodium Chloride Injection nationwide due to manufacturing deviations that could create product carryover.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA classified this as Class II. The product is an intravenous injection where any potential contamination due to manufacturing deviations represents a risk-of-harm situation. Although no illnesses have been reported and the contamination is potential rather than confirmed, the IV route of administration elevates the concern beyond precautionary measures.
Plain-English summary
Nephron Pharmaceuticals Corporation is recalling 378 bags of 0.9% Sodium Chloride Injection, USP (100 mL single-dose containers) distributed nationwide. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing that could result in trace amounts of product carryover.
The affected product is Lot 271043, with an expiration date of March 2023, NDC 0487-4301-10. This is a prescription intravenous injection.
Patients and healthcare providers in possession of affected units from this lot should not use the product. They should contact Nephron Pharmaceuticals or their healthcare provider for information about alternatives.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Nephron Sc Inc
- Category
- Drug — Intravenous Injection
- Hazard
- product-carryover
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 271043
- Exp. 03/2023
UPCs (6)
- 0304874301257
- 0000000000000
- 0304874301509
- 0304874301059
- 0304874301103
- 304874301103
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
- HighSodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
FDA (Drugs) · 2023-07-19
- HighSodium Chloride Injection Recalled Due to Storage Temperature Exposure Risk
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Sodium Chloride Injection Due to Incomplete Container Seals
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01